Pharmacology Corner

Articles related to ‘Drug safety’

• 

  FDA video: interaction of IV ceftriaxone with calcium-containing products

  8/03/09 • (0)

• More evidence that bisphosphonates do not increase the risk of atrial fibrillation (AF) or flutter

  3/16/09 • (0)

• FDA video warning about local anesthetics side effects

  3/15/09 • (0)

• Atomoxetine (Strattera) for ADHD: risk of psychotic or manic symptoms

  3/04/09 • (0)

• Metoclopramide and tardive dyskinesia: FDA adds boxed warning

  2/27/09 • (1)

• MHRA: Tibolone (Livial) increases risk of breast cancer recurrence

  2/23/09 • (0)

• Xigris (Drotrecogin alfa activated): concerns of serious bleeding and increased death trigger FDA safety review

  2/04/09 • (1)

• Atomoxetine (Strattera) and the risk of serious hepatic damage. FDA recommendations

  1/20/09 • (0)

• Hypersensitivity reactions to Abacavir (Ziagen, Trizivir and Epzicom): FDA does not recommended skin patch for screening

  1/20/09 • (0)

• Medwatch alert. Topical anesthetics: risk of cardiologic and neurologic side effects

  1/16/09 • (1)

• Atypical antipsychotics and sudden cardiac death: medical media coverage

  1/15/09 • (0)

• Important update on safety information of botulinum toxin type A (Botox)

  1/14/09 • (0)

• FDA updated information about a safety review of Ezetimibe/Simvastatin (Vytorin), Ezetimibe (Zetia), and Simvastatin (Zocor)

  1/09/09 • (0)

• Propolis side effects and association with renal failure: Health Canada case report

  1/06/09 • (0)

© 2010 • Continuing medical education in clinical Pharmacology and Therapeutics | Pharmamotion | Powered by WordPress & Mimbo

Blog Entries • Comments